Event

Portzamparc’s Biotech and Life Sciences Conference

Date : October 3, 2024

Company’s presentation and participation of the management team (virtual event)

Investor Access Event

October 15, 2024: MaaT Pharma Completes Recruitment of its ARES Phase 3 Trial for MaaT013 to Treat Acute Graft-versus-Host Disease